Registry Study for Radiation Therapy Outcomes

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Proton Collaborative Group
Information provided by (Responsible Party):
Proton Collaborative Group Identifier:
First received: December 6, 2010
Last updated: November 18, 2015
Last verified: November 2015
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Condition Intervention
Solid Tumors
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 10 Years
Official Title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy

Further study details as provided by Proton Collaborative Group:

Primary Outcome Measures:
  • Define outcomes for patients treated at participating institutions [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ] [ Designated as safety issue: Yes ]
  • Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ] [ Designated as safety issue: No ]

Estimated Enrollment: 7000
Study Start Date: June 2009
Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Treatment with Radiation Therapy
Includes 9 different arms to capture patient data by disease site
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Radiation Oncology patients

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01255748

Contact: Megan Dunn, PhD,MSHS 630-657-0092

United States, California
Scripps Health Proton Center Recruiting
San Diego, California, United States, 92121
Contact: Eileen Anderson    858-549-7524   
Principal Investigator: Carl Rossi, MD         
United States, Illinois
Northwestern Medicine Chicago Proton Center Recruiting
Warrenville, Illinois, United States, 60555
Contact: Shirley Samuel, PhD    630-821-6397   
Principal Investigator: William Hartsell, MD         
United States, Louisiana
Willis-Knighton Cancer and Proton Therapy Center Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Briana Barrow, CCRC    318-212-8671   
Principal Investigator: L. Ben Wilkinson, MD         
United States, New Jersey
ProCure Proton Therapy Center Recruiting
Somerset, New Jersey, United States, 08873
Contact: Carl Brown    732-357-2676   
Principal Investigator: Henry Tsai, MD         
United States, Oklahoma
ProCure Proton Therapy Center Recruiting
Oklahoma City, Oklahoma, United States, 73142
Contact: Kayla Tarrant    405-773-6775   
Principal Investigator: Gary Larson, MD         
United States, Virginia
Hampton University Proton Therapy Institute Recruiting
Hampton, Virginia, United States, 23666
Contact: Ed Dickey    757-251-6839   
Principal Investigator: Christopher Sinesi, MD         
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195-6043
Contact: Jessica Armand    206-598-8629   
Principal Investigator: George Laramore, MD         
Sponsors and Collaborators
Proton Collaborative Group
Study Chair: Carlos Vargas, MD Proton Collaborative Group
  More Information

Additional Information:
No publications provided

Responsible Party: Proton Collaborative Group Identifier: NCT01255748     History of Changes
Other Study ID Numbers: REG001-09
Study First Received: December 6, 2010
Last Updated: November 18, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Proton Collaborative Group:
cancer, proton, radiation processed this record on November 27, 2015